No connection

Search Results

JBTM

NEUTRAL
$129.08 Live
JBT Marel Corporation · NYSE
Target $183.5 (+42.2%)
$99.84 52W Range $170.19

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 29, 2026
Market cap
$6.72B
P/E
N/A
ROE
-1.7%
Profit margin
-1.3%
Debt/Equity
0.44
Dividend yield
0.31%

AI Analysis

AI-powered fundamental assessment

Confidence
80%
JBTM presents a stark contrast between explosive top-line growth and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 2/9. While revenue growth is exceptional at 115.60% YoY and analysts maintain a bullish target price of $183.50, the company is currently struggling with negative profit margins (-1.33%) and negative ROE (-1.65%). Liquidity is a concern with a Quick Ratio of 0.45, and insider sentiment is bearish with significant selling by the CEO and Directors. The stock is a high-growth play with significant underlying financial instability.

Key Strengths

Exceptional Revenue Growth (115.60% YoY)
Strong track record of earnings beats (3/4 last 4 quarters)
Attractive Forward P/E of 13.91 relative to growth
Healthy Gross Margin of 35.14%
Significant upside to analyst target price ($183.50)

Key Risks

Very weak financial health (Piotroski F-Score: 2/9)
Negative net profit margins and negative ROE
Poor short-term liquidity (Quick Ratio: 0.45)
Bearish insider activity with $7.15M in recent sales
Technical trend is currently bearish (0/100)
AI Fair Value Estimate
Based on comprehensive analysis
$156.29
+21.1% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
51
Moderate
Value
65
Future
88
Past
50
Health
20
Dividend
30
AI Verdict
Speculative Growth
Key drivers: Hyper-growth in revenue, Poor fundamental health scores, Insider divestment, Reasonable forward valuation
Confidence
85%
Value
65/100

Ref Forward P/E and PEG Ratio

Positives
  • Forward P/E is low (13.91)
  • PEG ratio of 1.22 suggests fair pricing for growth
Watchpoints
  • P/B of 1.50 is moderate but not a deep value
Future
88/100

Ref Revenue Growth and Earnings Track Record

Positives
  • Triple-digit revenue growth (115.6% YoY)
  • Consistent earnings surprises (+16% avg)
Watchpoints
  • Sustainability of 100%+ growth is questionable
Past
50/100

Ref Price Performance Snapshot

Positives
  • Strong 1Y price return (+25.2%)
Watchpoints
  • Negative 5Y price change (-10.3%)
Health
20/100

Ref Piotroski F-Score and Liquidity Ratios

Positives
  • Manageable Debt/Equity ratio (0.44)
Watchpoints
  • Piotroski F-Score of 2/9 indicates weak health
  • Quick Ratio of 0.45 suggests liquidity risk
  • Negative ROE and Profit Margins
Dividend
30/100

Ref Dividend Yield and Payout Ratio

Positives
  • Low payout ratio (15.21%) suggests sustainability
Watchpoints
  • Negligible dividend yield (0.31%)

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$129.08
Analyst Target
$183.5
Upside/Downside
+42.2%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for JBTM and closest competitors.

Updated 2026-04-28
JBT
JBT Marel Corporation
Primary
5Y
-10.3%
3Y
+20.0%
1Y
+25.2%
6M
+1.2%
1M
+5.1%
1W
-2.7%
MID
The Middleby Corporation
Peer
5Y
-13.1%
3Y
+2.5%
1Y
+8.1%
6M
+8.1%
1M
-0.4%
1W
+5.6%
ADT
ADT Inc.
Peer
5Y
+1.2%
3Y
+0.3%
1Y
+11.5%
6M
-3.6%
1M
-0.6%
1W
-2.7%
GXO
GXO Logistics, Inc.
Peer
5Y
+4.9%
3Y
+7.6%
1Y
+59.0%
6M
+4.5%
1M
+15.1%
1W
-3.6%
FLR
Fluor Corporation
Peer
5Y
+114.9%
3Y
+67.2%
1Y
+35.5%
6M
-1.5%
1M
+0.6%
1W
-0.7%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
13.91
PEG Ratio
1.22
P/B Ratio
1.5
P/S Ratio
1.77
EV/Revenue
2.24
EV/EBITDA
20.01
Market Cap
$6.72B

Profitability

Profit margins and return metrics

Profit Margin -1.33%
Operating Margin 9.17%
Gross Margin 35.14%
ROE -1.65%
ROA 2.0%

Growth

Revenue and earnings growth rates

Revenue Growth +115.6%
Earnings Growth N/A
Q/Q Revenue Growth +122.12%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.44
Low debt
Current Ratio
0.98
Weak
Quick Ratio
0.45
Poor
Cash/Share
$3.23

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$1.0B
Gross Margin
34.5%
Op. Margin
7.9%
Net Margin
5.3%
Total Assets
$8.2B
Liabilities
$3.7B
Equity
$4.5B
Debt/Equity
0.83x
Operating CF
$0.1B
CapEx
$-0.0B
Free Cash Flow
$0.1B
FCF Yield
71%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-04
$N/A
2026-02-23
$1.98
+2.7% surprise
2025-11-03
$1.94
+28.9% surprise
2025-08-04
$1.49
+16.4% surprise

Industrials Sector Comparison

Comparing JBTM against 482 companies in the Industrials sector (40 bullish, 179 neutral, 263 bearish)
Return on Equity (ROE)
-1.65%
This Stock
vs
-19.0%
Sector Avg
-91.3% (Below Avg)
Profit Margin
-1.33%
This Stock
vs
6.5%
Sector Avg
-120.5% (Weaker)
Debt to Equity
0.44
This Stock
vs
2.61
Sector Avg
-83.1% (Less Debt)
Revenue Growth
115.6%
This Stock
vs
69.73%
Sector Avg
+65.8% (Fast Growth)
Current Ratio
0.98
This Stock
vs
3.06
Sector Avg
-68.1% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

DECK BRIAN A.
Chief Executive Officer
Sell
2026-03-03
18,634 shares · $2,813,403
DECK BRIAN A.
Chief Executive Officer
Stock Award
2026-02-25
46,567 shares
PELLETIER JAMES C
General Counsel
Stock Award
2026-02-25
1,722 shares
MEISTER MATTHEW J
Chief Financial Officer
Stock Award
2026-02-25
10,391 shares
BRIDAROLLI SHELLEY RAE
Officer
Stock Award
2026-02-25
5,259 shares
PETRIE ROBERT JAMES
Officer
Stock Award
2026-02-25
6,700 shares
RIZZOLO LUIZ AUGUSTO
Officer
Stock Award
2026-02-25
6,021 shares
SIDDONS MARY BETH
Officer
Stock Award
2026-02-25
494 shares
SIGURDSSON ARNI
President
Stock Award
2026-02-25
3,253 shares
CLAESSENS ROGER
Officer
Stock Award
2026-02-25
1,786 shares
GUDMUNDSSON OLAFUR S
Director
Sell
2025-12-10
10,000 shares · $1,500,900
GUDMUNDSSON OLAFUR S
Director
Sell
2025-11-26
20,000 shares · $2,835,894
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

DEF 14A
DEF 14A
2026-04-01

JBTM filed a Definitive Proxy Statement (DEF 14A) on April 1, 2026, providing shareholders with necessary information and voting materials for the company's annual meeting.

8-K
8-K
2026-03-26

JBTM filed a current report on March 26, 2026, likely announcing its first-quarter financial results.

10-K
10-K
2026-03-02

JBTM filed its annual 10-K report on March 2, 2026. Specific financial highlights and risk factors were not provided in the available excerpts for detailed analysis.

8-K
8-K
2026-02-23

JBTM filed an 8-K on February 23, 2026, likely to announce its fourth quarter and full-year financial results.

8-K
8-K
2026-02-18

JBTM filed an 8-K on February 18, 2026, likely to announce its annual financial results for the fiscal year ended December 31, 2025.

10-Q
10-Q
2025-11-04

JBTM submitted its 10-Q filing on November 4, 2025, reporting no material changes to its previously disclosed risk factors. Specific financial highlights were not provided in the available excerpts.

8-K
8-K
2025-11-03

JBTM filed an 8-K on November 3, 2025, likely to report its third-quarter financial results.

8-K
8-K
2025-10-20

JBTM filed an 8-K on October 20, 2025, likely to report its third-quarter financial results.

8-K
8-K
2025-09-09
8-K
8-K
2025-09-03
8-K
8-K
2025-08-21
10-Q
10-Q
2025-08-07
8-K
8-K
2025-08-05
8-K
8-K
2025-05-20
8-K
8-K
2025-05-05
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
NONE
5 analysts
Jefferies
2025-12-10
up
Hold Buy

Past News Coverage

Recent headlines mentioning JBTM from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile